Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OGT to Host Company Showcase at BioTrinity 2012

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
Seminar to discuss company’s biomarker accelerator strategy for optimizing drug and diagnostic development.

Oxford Gene Technology (OGT) will be discussing its biomarker discovery offering at the European Biopartnering and Investment Conference, BioTrinity, from 24th-26th April in Newbury, UK.

The conference will include a Company Showcase from OGT’s CEO, Dr Mike Evans, which takes place at 4.20 pm on Wednesday 25th April.

The talk will provide an overview of OGT’s corporate strategy, which has delivered significant and sustained revenue growth, with particular focus on the company’s Diagnostic Biomarkers business unit.

OGT Diagnostic Biomarkers utilizes proprietary next generation technologies to identify informative biomarkers for early-stage detection of cancer and autoimmune disease.

Through a combination of the implementation of a unique Biomarker Accelerator Strategy and in-house discovery, OGT is building a rich patent-protected portfolio of promising biomarkers for a number of diseases where there are clear clinical needs and markets for improved diagnostic tests.

Details of this strategy and OGT’s additional biomarker discovery and validation services will be given in the presentation.

In a recent example of OGT’s Biomarker Accelerator Strategy, OGT entered into an exclusive licensing deal with Inven2, the technology transfer office at Oslo University Hospital and the University of Oslo.

Using 12 highly promising colorectal cancer tissue biomarkers developed at Oslo University Hospital, OGT now has an exclusive license to commercialize any resulting test developed with the biomarkers.

As a well-established private molecular diagnostics and clinical solutions company actively operating in 30 countries worldwide, OGT has a strong position in the large and rapidly growing molecular medicine market.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OGT Appoints Dr Bob Holland as CMO
Company strengthens focus on cancer biomarkers.
Monday, October 21, 2013
Scientific News
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.
Game Changing Antibacterial Drug Research
Researchers publish report on the synthesis of a newly discovered “game-changing” antibiotic, Teixobactin.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
New Way of Displaying 3D Molecular Structures
Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples.
Agent Blocks Pain Without Morphine's Side Effects
Scientists have synthesised a molecule with specific pain-relief properties and has shown its efficacy in mice.
Cutting the Cost of Drug-Building Chemicals
EPFL scientists have developed a method to produce aryl-containing amines in a cheap and easily scalable way.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!